Human coagulation factor VIII (China Biologic Products)

人凝血因子VIII（中国生物制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman coagulation factor VIII (China Biologic Products)
Drug Alias Name人凝血因子VIII（中国生物制品有限公司）Human coagulation factor VIII (Shandong Taibang)
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhageHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2012/06/15
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaibang Biotech (Shandong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaibang Biotech (Shandong) Co LtdGuizhou Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsBlood Loss, SurgicalHemorrhageHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A